Connection

Maria Matheus to Sirolimus

Back to Details
This is a "connection" page, showing publications Maria Matheus has written about Sirolimus.
Maria Matheus
Connection Strength
0.149
Sirolimus
  1. Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial. Clin Cancer Res. 2019 02 15; 25(4):1156-1164.
    View in: PubMed
    Score: 0.149
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.